Announcements
- Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
- Annual General Meeting of Kuros Biosciences approves all resolutions
- Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
- Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
Key statistics
On Thursday, Kuros Biosciences AG (0RHR:LSE) closed at 7.97, -3.74% below its 52-week high of 8.28, set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 7.97 |
Average volume | 577.29 |
---|---|
Shares outstanding | 36.92m |
Free float | 23.93m |
P/E (TTM) | -- |
Market cap | 295.01m CHF |
EPS (TTM) | -0.3697 CHF |
Data delayed at least 20 minutes, as of May 23 2024 16:11 BST.
More ▼